Cargando…

Enhanced osteoblastic differentiation of parietal bone in a novel murine model of mucopolysaccharidosis type II

Mucopolysaccharidosis type II (MPS II, OMIM 309900) is an X-linked disorder caused by a deficiency of lysosomal enzyme iduronate-2-sulfatase (IDS). The clinical manifestations of MPS II involve cognitive decline, bone deformity, and visceral disorders. These manifestations are closely associated wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamazaki, Narutoshi, Ohira, Mari, Takada, Shuji, Ohtake, Akira, Onodera, Masafumi, Nakanishi, Mahito, Okuyama, Torayuki, Mashima, Ryuichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694741/ http://dx.doi.org/10.1016/j.ymgmr.2023.101021

Ejemplares similares

A novel mucopolysaccharidosis type II mouse model with an iduronate-2-sulfatase-P88L mutation
por: Mashima, Ryuichi, et al.
Publicado: (2023)

Quantification of 11 enzyme activities of lysosomal storage disorders using liquid chromatography-tandem mass spectrometry
por: Ohira, Mari, et al.
Publicado: (2018)

Biomarkers for Lysosomal Storage Disorders with an Emphasis on Mass Spectrometry
por: Mashima, Ryuichi, et al.
Publicado: (2020)

Biosynthesis of long chain base in sphingolipids in animals, plants and fungi
por: Mashima, Ryuichi, et al.
Publicado: (2019)

Physiology and Pathophysiology of Heparan Sulfate in Animal Models: Its Biosynthesis and Degradation
por: Mashima, Ryuichi, et al.
Publicado: (2022)

The levels of urinary glycosaminoglycans of patients with attenuated and severe type of mucopolysaccharidosis II determined by liquid chromatography-tandem mass spectrometry
por: Mashima, Ryuichi, et al.
Publicado: (2016)

Quantification of the enzyme activities of iduronate-2-sulfatase, N-acetylgalactosamine-6-sulfatase and N-acetylgalactosamine-4-sulfatase using liquid chromatography-tandem mass spectrometry
por: Mashima, Ryuichi, et al.
Publicado: (2017)

LC-MS/MS-based enzyme assay for lysosomal acid lipase using dried blood spots
por: Ohira, Mari, et al.
Publicado: (2022)

The role of lipoxygenases in pathophysiology; new insights and future perspectives
por: Mashima, Ryuichi, et al.
Publicado: (2015)

Enzyme activities of α-glucosidase in Japanese neonates with pseudodeficiency alleles
por: Mashima, Ryuichi, et al.
Publicado: (2017)

A molecular analysis of the GAA gene and clinical spectrum in 38 patients with Pompe disease in Japan
por: Fukuhara, Yasuyuki, et al.
Publicado: (2017)

Mammalian Sulfatases: Biochemistry, Disease Manifestation, and Therapy
por: Mashima, Ryuichi, et al.
Publicado: (2022)

Structural Basis of Mucopolysaccharidosis Type II and Construction of a Database of Mutant Iduronate 2-Sulfatases
por: Saito, Seiji, et al.
Publicado: (2016)

Impact of intracerebroventricular enzyme replacement therapy in patients with neuronopathic mucopolysaccharidosis type II
por: Seo, Joo-Hyun, et al.
Publicado: (2021)

Levels of enzyme activities in six lysosomal storage diseases in Japanese neonates determined by liquid chromatography-tandem mass spectrometry
por: Mashima, Ryuichi, et al.
Publicado: (2016)

Enzyme replacement therapy attenuates disease progression in two Japanese siblings with mucopolysaccharidosis type VI: 10-Year follow up
por: Furujo, Mahoko, et al.
Publicado: (2017)

Natural history of cognitive development in neuronopathic mucopolysaccharidosis type II (Hunter syndrome): Contribution of genotype to cognitive developmental course
por: Seo, Joo-Hyun, et al.
Publicado: (2020)

Elevation of plasma lysosphingomyelin-509 and urinary bile acid metabolite in Niemann-Pick disease type C-affected individuals
por: Mashima, Ryuichi, et al.
Publicado: (2018)

Lipid Nanoparticles: A Novel Gene Delivery Technique for Clinical Application
por: Mashima, Ryuichi, et al.
Publicado: (2022)

Lysosomal Acid Lipase Deficiency: Genetics, Screening, and Preclinical Study
por: Mashima, Ryuichi, et al.
Publicado: (2022)

Diagnosis and treatment trends in mucopolysaccharidosis I: findings from the MPS I Registry
por: D’Aco, Kristin, et al.
Publicado: (2012)

A selective detection of lysophosphatidylcholine in dried blood spots for diagnosis of adrenoleukodystrophy by LC-MS/MS
por: Mashima, Ryuichi, et al.
Publicado: (2016)

Iduronate-2-Sulfatase with Anti-human Transferrin Receptor Antibody for Neuropathic Mucopolysaccharidosis II: A Phase 1/2 Trial
por: Okuyama, Torayuki, et al.
Publicado: (2019)

A cDNA analysis disclosed the discordance of genotype-phenotype correlation in a patient with attenuated MPS II and a 76-base deletion in the gene for iduronate-2-sulfatase
por: Fukuhara, Yasuyuki, et al.
Publicado: (2020)

RNA-Based Therapeutic Technology
por: Mashima, Ryuichi, et al.
Publicado: (2023)

Enzyme Replacement Therapy with Pabinafusp Alfa for Neuronopathic Mucopolysaccharidosis II: An Integrated Analysis of Preclinical and Clinical Data
por: Giugliani, Roberto, et al.
Publicado: (2021)

Normal early development in siblings with novel compound heterozygous variants in ASPM
por: Moriwaki, Taro, et al.
Publicado: (2020)

Genotype‐phenotype relationships in mucopolysaccharidosis type I (MPS I): Insights from the International MPS I Registry
por: Clarke, Lorne A., et al.
Publicado: (2019)

Distribution of Heparan Sulfate Oligosaccharides in Murine Mucopolysaccharidosis Type IIIA
por: Mason, Kerryn, et al.
Publicado: (2014)

Neurocognitive testing in a murine model of mucopolysaccharidosis type IIIA
por: Pericleous, Kleopatra, et al.
Publicado: (2023)

Osteoarthropathy in mucopolysaccharidosis type II
por: NASCU, IOANA, et al.
Publicado: (2013)

Development of Substrate Degradation Enzyme Therapy for Mucopolysaccharidosis IVA Murine Model
por: Sawamoto, Kazuki, et al.
Publicado: (2019)

The second report on spondyloepimetaphyseal dysplasia, aggrecan type: a milder phenotype than originally reported
por: Fukuhara, Yasuyuki, et al.
Publicado: (2019)

Sexual behaviour in a murine model of mucopolysaccharidosis type I (MPS I)
por: Barbosa Mendes, Ana, et al.
Publicado: (2019)

Cervical spondylolisthesis in mucopolysaccharidosis type II
por: Rossi, Alessandro, et al.
Publicado: (2022)

Representation of the Numerosity ‘zero’ in the Parietal Cortex of the Monkey
por: Okuyama, Sumito, et al.
Publicado: (2015)

Mucopolysaccharidosis VI
por: Valayannopoulos, Vassili, et al.
Publicado: (2010)

The Murine Model of Mucopolysaccharidosis IIIB Develops Cardiopathies over Time Leading to Heart Failure
por: Schiattarella, Gabriele Giacomo, et al.
Publicado: (2015)

Novel Enzyme Replacement Therapies for Neuropathic Mucopolysaccharidoses
por: Sato, Yuji, et al.
Publicado: (2020)

Review of the use of idursulfase in the treatment of mucopolysaccharidosis II
por: Burrow, T Andrew, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_k2hvo5eukcjpgehbjecvi6rakh